UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050792
Receipt number R000057880
Scientific Title Risk assessment of bleeding after gastric submucosal dissection in patients taking anticoagulant drugs and validity evaluation of supplemented guideline for gastrointestinal endoscopy in patients taking antithrombotic drugs: multicenter observational study
Date of disclosure of the study information 2023/04/09
Last modified on 2023/04/09 17:16:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Risk assessment of bleeding after gastric submucosal dissection in patients taking anticoagulant drugs and validity evaluation of supplemented guideline for gastrointestinal endoscopy in patients taking antithrombotic drugs: multicenter observational study

Acronym

Risk assessment of bleeding after gastric submucosal dissection in patients taking anticoagulant drugs and validity evaluation of supplemented guideline for gastrointestinal endoscopy in patients taking antithrombotic drugs: multicenter observational study

Scientific Title

Risk assessment of bleeding after gastric submucosal dissection in patients taking anticoagulant drugs and validity evaluation of supplemented guideline for gastrointestinal endoscopy in patients taking antithrombotic drugs: multicenter observational study

Scientific Title:Acronym

Risk assessment of bleeding after gastric submucosal dissection in patients taking anticoagulant drugs and validity evaluation of supplemented guideline for gastrointestinal endoscopy in patients taking antithrombotic drugs: multicenter observational study

Region

Japan


Condition

Condition

early gastric cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To compare the postoperative bleeding rate before and after the publication of the Guideline for Gastrointestinal Endoscopy for Patients Taking Antithrombotic Drugs (Amendment 2017), targeting cases of patients taking anticoagulants who underwent ESD according to the guidelines of the Japan Gastric Cancer Society. , and to evaluate the adequacy of management in accordance with the guidelines for gastrointestinal endoscopy for patients taking antithrombotic drugs.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation of the postoperative bleeding rate before and after the revised guideline in patients taking antithrombotic drugs during gastric ESD in patients taking anticoagulants.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Those who are 20 years of age or older
2. Those who have undergone ESD treatment for early gastric cancer in accordance with the "Stomach Cancer Treatment Guidelines" edited by the Japan Gastric Cancer Society
3. Those taking anticoagulants (warfarin or DOAC)
4. Those who have undergone ESD treatment for early gastric cancer in accordance with the "Guidelines for Gastrointestinal Endoscopy for Patients Taking Antithrombotic Drugs" edited by the Japan Gastroenterological Endoscopy Society or its supplements.

Key exclusion criteria

1. Patients who discontinued ESD or underwent surgical treatment due to complications (bleeding, perforation, etc.) or technical reasons during ESD.
2. Those who have not been able to follow up for more than 28 days after ESD
3. Subjects who received additional photodynamic therapy (PDT) after ESD
4. Patients with infiltration deeper than the muscle layer in histopathological evaluation of the resected specimen
5. Patients participating in other interventional trials
6. Those who refuse to use clinical data

Target sample size

1740


Research contact person

Name of lead principal investigator

1st name Masaki
Middle name
Last name Murata

Organization

National Hospital Organization Kyoto Medical Center

Division name

Department of gastroenterology

Zip code

612-8555

Address

1-1, Mukouhata-Cho, Fukakusa, Fushimi-ku, Kyoto, Japan

TEL

+81756419161

Email

mura05310531@gmail.com


Public contact

Name of contact person

1st name Masaki
Middle name
Last name Murata

Organization

National Hospital Organization Kyoto Medical Center

Division name

Department of gastroenterology

Zip code

612-8555

Address

1-1, Mukouhata-Cho, Fukakusa, Fushimi-ku, Kyoto, Japan

TEL

+81756419161

Homepage URL


Email

mura05310531@gmail.com


Sponsor or person

Institute

National Hospital Organization Kyoto Medical Center

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization Kyoto Medical Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Tokyo Medical University
Kyoto Medical Center
University of Tokyo
Tohoku University
National Cancer Center Hospital
Fukushima Medical University Hospital
University of Tsukuba Hospital
Hirosaki University
Toyonaka Municipal Hospital
Jikei University Hospital
National Center for Global Health and Medicine Konodai Hospital
Hamamatsu University School of Medicine
Tokyo Metropolitan Bokuto Hospital
Iwate Medical University
Seirei Hamamatsu Hospital
Nihon University
Kansai Rosai Hospital
Kagawa University Medical School Hospital
Yamaguchi University Graduate School
Cancer Research Ariake Hospital
Sendai Kosei Hospital
Osaka Public University
Osaka University
Wakayama Medical University
Hyogo College of Medicine
Osaka Municipal General Medical Center
Tonan Hospital
Chiba University
Ehime University Hospital
Ishikawa Prefectural Central Hospital
Shizuoka Cancer Center
Gunma University Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Kyoto Medical Center

Address

1-1, Mukouhata-Cho, Fukakusa, Fushimi-ku, Kyoto, Japan

Tel

+81756419161

Email

mura05310531@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

1740

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 12 Month 19 Day

Date of IRB

2022 Year 12 Month 19 Day

Anticipated trial start date

2023 Year 04 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Aims
1. Evaluation of the postoperative bleeding rate before and after the revised guideline in patients taking antithrombotic drugs during gastric ESD in patients taking anticoagulants
2. Validity evaluation of the supplemented guideline in patients taking antithrombotic drugs during gastric ESD in patients taking anticoagulants


Management information

Registered date

2023 Year 04 Month 09 Day

Last modified on

2023 Year 04 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057880